Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : EXAI save search
Exscientia Business and Financial Update for the Full Year 2023
Published: 2024-03-21 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
EXAI | $4.33 -1.14% 77K
|
|
| O: -3.35%
H: 0.0%
C: -7.39%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
business year update financial
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: -0.88%
H: 1.66%
C: -1.04%
report year financial results
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 1.02%
H: 0.0%
C: -1.68%
precision cancer study platform
Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza
Published: 2023-12-05 (Crawled : 16:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: -0.32%
H: 1.46%
C: 0.49%
influenza grant
Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference
Published: 2023-11-21 (Crawled : 19:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 0.52%
H: 0.26%
C: -8.03%
conference
Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
Published: 2023-09-20 (Crawled : 09:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 20.95%
H: 0.0%
C: -25.98%
drug merck germany collaboration
Exscientia Business Update for Second Quarter and First Half of 2023
Published: 2023-08-10 (Crawled : 12:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 0.0%
H: 0.73%
C: -6.74%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 1.52%
H: 1.05%
C: 0.47%
business update
Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023
Published: 2023-08-03 (Crawled : 12:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: -2.63%
H: 6.27%
C: 3.32%
report financial results
Exscientia Initiates Prospective Observational Study in Ovarian Cancer
Published: 2023-07-18 (Crawled : 15:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 2.19%
H: 2.27%
C: 0.4%
cancer study
First Patient Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours
Published: 2023-07-10 (Crawled : 12:20) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 0.88%
H: 11.11%
C: 6.03%
taexs617 trial
Exscientia Announces Expansion of its Technology Leadership Team
Published: 2023-06-29 (Crawled : 13:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: -0.5%
H: 1.32%
C: -8.04%
expansion technology
Exscientia to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
Published: 2023-06-06 (Crawled : 13:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 1.43%
H: 7.56%
C: 6.41%
conference global
Exscientia Business Update for First Quarter 2023
Published: 2023-05-24 (Crawled : 12:20) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: -3.81%
H: 10.66%
C: 10.25%
business update
Exscientia Highlights "The Future of AI-enabled Drug Discovery" at SLAS Europe
Published: 2023-05-22 (Crawled : 12:20) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 1.66%
H: 27.04%
C: 25.24%
europe drug
Exscientia to Report First Quarter 2023 Financial Results on May 24, 2023
Published: 2023-05-17 (Crawled : 12:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 1.12%
H: 5.56%
C: 5.0%
report financial results
Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors
Published: 2023-05-03 (Crawled : 12:00) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 0.0%
H: 8.25%
C: 4.95%
Exscientia Business and Financial Update for the Full Year 2022
Published: 2023-03-23 (Crawled : 12:20) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 5.54%
H: 0.96%
C: 0.96%
EXAI | $4.33 -1.14% 77K
|
|
| O: 2.86%
H: 9.89%
C: 7.42%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 6.53%
H: 0.56%
C: -0.54%
business year update financial
Exscientia to Report Full Year 2022 Financial Results on March 23, 2023
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 1.82%
H: 3.71%
C: 3.42%
report year financial results
Exscientia to Present Data Highlighting Pipeline and Precision Medicine Platform at AACR
Published: 2023-03-15 (Crawled : 12:20) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: -1.59%
H: 1.97%
C: -2.79%
pipeline platform
Exscientia Announces Expansion of its Precision Oncology Pipeline
Published: 2023-03-14 (Crawled : 12:20) - biospace.com/
EXAI | $4.33 -1.14% 77K
|
|
| O: 4.05%
H: 0.43%
C: -0.43%
expansion pipeline
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
RILY | $30.325 39.62% 6.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.